共 256 条
[1]
Argyriou AA(1990)A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck Br J Cancer 61 311-315
[2]
Chroni E(2005)Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial Neurology 64 26-31
[3]
Koutras A(1994)Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group Ann Oncol 5 521-526
[4]
Ellul J(1992)Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study J Clin Oncol 10 1245-1251
[5]
Papapetropoulos S(1998)Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390) Cancer 82 2270-2274
[6]
Katsoulas G(1994)Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck ORL J Otorhinolaryngol Relat Spec 56 279-282
[7]
Iconomou G(1999)Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer J Clin Oncol 17 3038-3047
[8]
Kalofonos HP(2009)Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients Acta Otolaryngol 129 1294-1299
[9]
Clavel M(1999)Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent head and neck cancer Gan To Kagaku Ryoho 26 107-116
[10]
Vermorken JB(1998)Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group) Gan To Kagaku Ryoho 25 1151-1158